Results of a study conducted in Switzerland indicate that selective digestive decontamination, a controversial strategy designed to reduce the risk of in­fec­tions, may be effective in myeloma patients undergoing au­tol­o­gous (own) stem cell trans­plan­ta­tion.

The authors of the new study retro­spec­tive­ly reviewed data for over 200 myeloma patients who underwent an inpatient stem cell trans­plant at two hos­pi­tals in Zurich, Switzerland, be­tween 2009 and 2015. About half the patients underwent selective digestive decontamination (SDD) during their trans­plants, while the other half did not.

The patients who underwent SDD were sig­nif­i­cantly less likely …